Copyright
©The Author(s) 2020.
World J Cardiol. Jul 26, 2020; 12(7): 342-350
Published online Jul 26, 2020. doi: 10.4330/wjc.v12.i7.342
Published online Jul 26, 2020. doi: 10.4330/wjc.v12.i7.342
Table 1 Characteristics of hepatic cirrhosis patients stratified by presence of atrial fibrillation among 2003-2014
Characteristic | Non-AF (n = 651192) | AF (n = 45745) | P value |
Age (mean ± SD, yr) | 54 ± 11 | 65 ± 11 | < 0.001 |
Female, n (%) | 171592 (28.3) | 9244 (20.2) | < 0.001 |
Race, n (%) | < 0.001 | ||
Caucasian | 343516 (65.8) | 30624 (76.2) | |
African American | 57718 (11.1) | 3674 (9.1) | |
Hispanic | 91439 (17.5) | 4130 (10.3) | |
Medical comorbidity, n (%) | |||
Hypertension | 215381 (35.7) | 23136 (50.7) | < 0.001 |
Diabetes mellitus | 126047 (20.8) | 12282 (26.8) | < 0.001 |
Prior sternotomy | 8602 (1.4) | 2926 (6.4) | < 0.001 |
Chronic pulmonary disease | 106826 (17.6) | 14176 (31) | < 0.001 |
Chronic renal failure | 62065 (10.3) | 9884 (21.6) | < 0.001 |
Anemia | 186205 (30.8) | 13771 (30.1) | 0.004 |
Chronic alcohol use | 418372 (69.1) | 29194 (63.8) | < 0.001 |
Hypothyroidism | 35221 (5.8) | 4662 (10.2) | < 0.001 |
Peripheral vascular disease | 16026 (2.6) | 3518 (7.7) | < 0.001 |
Smoking | 159957 (26.4) | 8420 (18.4) | < 0.001 |
Coronary artery disease | 31636 (5.2) | 6994 (15.3) | < 0.001 |
Hospital characteristic, n (%) | |||
Teaching hospital | 303751 (50.4) | 22069 (48.4) | < 0.001 |
Rural area | 57619 (9.6) | 4378 (9.6) | 0.761 |
Hospital bed-size | < 0.001 | ||
Small | 72730 (12.1) | 5903 (13) | |
Medium | 156654 (26) | 11616 (25.5) | |
Large | 373165 (61.9) | 28057 (61.6) | |
Primary payer, n (%) | < 0.001 | ||
Medicare/Medicaid | 350547 (57.9) | 33371 (73) | |
Private including HMO | 140515 (23.2) | 8278 (18.1) | |
Self-pay | 72366 (12) | 2287 (5) |
Table 2 Characteristics of propensity matched hepatic cirrhosis patients stratified by presence of atrial fibrillation among 2003-2014
Characteristic | Non-AF (n = 45504) | AF (n = 45504) | P value |
Age (mean ± SD, yr) | 65 ± 11 | 65 ± 11 | 0.827 |
Female, n (%) | 9174 (20.2) | 9221 (20.3) | 0.703 |
Race, n (%) | 0.561 | ||
Caucasian | 34548 (75.9) | 34633 (76.1) | |
African American | 4314 (9.5) | 4179 (9.2) | |
Hispanic | 4644 (10.2) | 4692 (10.3) | |
Medical comorbidity, n (%) | |||
Hypertension | 23142 (50.9) | 22972 (50.5) | 0.251 |
Diabetes mellitus | 12456 (27.4) | 12229 (26.9) | 0.091 |
Prior sternotomy | 2610 (5.7) | 2843 (6.2) | 0.07 |
Chronic pulmonary disease | 14165 (31.1) | 14051 (30.9) | 0.404 |
Chronic renal failure | 9595 (21.1) | 9751 (21.4) | 0.192 |
Anemia | 13623 (29.9) | 13690 (30.1) | 0.634 |
Chronic alcohol use | 29054 (63.8) | 29060 (63.9) | 0.972 |
Hypothyroidism | 4456 (9.8) | 4603 (10.1) | 0.103 |
Peripheral vascular disease | 3420 (7.5) | 3463 (7.6) | 0.592 |
Smoking | 8264 (18.2) | 8405 (18.5) | 0.222 |
Coronary artery disease | 6893 (15.1) | 6898 (15.2) | 0.969 |
Hospital characteristic, n (%) | |||
Teaching hospital | 22061 (48.5) | 22129 (48.6) | 0.567 |
Rural area | 41154 (90.4) | 41141 (90.4) | 0.893 |
Hospital bed-size | 0.253 | ||
Small | 6062 (13.3) | 5871 (12.9) | |
Medium | 11469 (25.2) | 11569 (25.4) | |
Large | 27973 (61.5) | 28064 (61.7) | |
Primary payer, n (%) | 0.052 | ||
Medicare/ Medicaid | 33277 (73.1) | 33138 (72.8) | |
Private including HMO | 8389 (18.4) | 8270 (18.2) | |
Self-pay | 2101 (4.6) | 2287 (5) |
Table 3 In-hospital outcomes of propensity matched hepatic cirrhosis patients stratified by presence of atrial fibrillation among 2003-2014
Non-AF (n = 45504) | AF (n = 45504) | P value | |
Clinical outcome, n (%) | |||
In-hospital death | 4697 (10.3) | 5755 (12.6) | < 0.001 |
Gastrointestinal bleeding | 2329 (5.1) | 1995 (4.4) | < 0.001 |
Blood transfusion | 10841 (23.8) | 10219 (22.5) | < 0.001 |
Transient ischemic attack | 124 (0.3) | 134 (0.3) | 0.575 |
Clinical stroke | 496 (1.1) | 722 (1.6) | < 0.001 |
Acute kidney injury | 11433 (25.1) | 12810 (28.2) | < 0.001 |
Discharge status, n (%) | < 0.001 | ||
Discharged home | 27646 (60.8) | 25705 (56.5) | |
Discharged SNF/NH/IC | 12242 (26.9) | 13114 (28.8) | |
Length of stay (mean ± SD, d) | 7 ± 8 | 8 ± 10 | < 0.001 |
Hospital cost (mean ± SD, $) | 16272 ± 24166 | 20720 ± 33210 | < 0.001 |
Table 4 The prevalence of atrial fibrillation according to age and gender for in-patients with liver cirrhosis compared to the general in-patient population
Age (yr) | Gender | AF in liver cirrhosis (%) | AF national estimate (%) |
< 45 | Male | 1.70 | 1.76 |
Female | 0.90 | 0.88 | |
46-65 | Male | 5.90 | 5.91 |
Female | 3.20 | 3.16 | |
66-85 | Male | 20.00 | 20.03 |
Female | 16.00 | 15.99 | |
> 86 | Male | 34.10 | 34.18 |
Female | 33.50 | 33.60 |
- Citation: Darrat YH, Smer A, Elayi CS, Morales GX, Alqahtani F, Alkhouli M, Catanzaro J, Shah J, Salih M. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World J Cardiol 2020; 12(7): 342-350
- URL: https://www.wjgnet.com/1949-8462/full/v12/i7/342.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i7.342